- UK’s largest NHS-funded IVF service and related research programme: 1 in 6 couples in the UK experience fertility problems and seek specialist reproductive medicine services. St Mary’s established the first NHS-funded IVF service in the UK in 1983. Manchester is a major UK centre for fertility preservation for cancer patients, including sperm, oocyte and ovarian tissue cryopreservation. The reproductive medicine service hosts clinical trials in IVF treatments and research into early human embryo development, implantation and child growth. Our fertility preservation clinic stores tissue from men and women undergoing cancer treatments, including sperm (since 1977), ovarian tissue (since 1996) and oocytes (2010).
- Gynaecology services: Our Gynaecology research portfolio is extensive and includes gynaecological cancer, fertility, early human development, pregnancy disorders and urogynaecology.
- Full maternity care for women: Manchester is home to the Maternal and Fetal Health Research Centre, the largest pregnancy research group in Europe. NHS and university clinical staff and researchers work together on our innovative and successful clinical research clinics that improve fertility and pregnancy outcomes and maternity care. The Manchester Antenatal Vascular Clinic helps women who have a high risk of hypertension in pregnancy by providing additional monitoring, scans & support. The Rainbow Clinic helps women and their families who have experienced the death of a baby in a previous pregnancy. These, and our other clinical research clinics, are unique to Manchester.
- Comprehensive specialist paediatric services: including paediatric ophthalmology, burns and plastics, dental and CAMHS services. Based on our specialist expertise in managing rare diseases, we have strong representation in the European Reference Networks.
- We are the North West’s major centre for Genetic Medicine. Rare diseases are those that affect fewer than 1 in 2,000 people. In the UK, 1 in 17 people are affected by a rare disease. The majority of such diseases are inherited. The Manchester Centre for Genomic Medicine has a stellar research programme defining the causes of many rare diseases, using new genetic technologies including next generation sequencing and developing treatment strategies based on this new information.
Women & Children Research Domain
The MAHSC Women & Children’s Research Domain collaborates closely with Greater Manchester universities to ensure that scientific discoveries can be channelled towards clinical practice.
The Domain operates across 5 key themes:
Manchester aims to be a leading centre in the UK, and internationally, for the promotion of the health and well-being of women and children.
Theme and Clinical Leads
Selected activity ongoing within the domain:
- PALOH – neonatal point of care testing for gentamicin toxicity
- Digital Assessment of Wellbeing in New Parents (DAWN-P)
- Impress: developing predictive algorithms in ovarian cancer
- A GM-wide paediatrics collaboration workshop and showcase event, 30th November 2021
- A GM Gynaecology research and clinical collaboration event, 24th January 2023
- Small funding awards – further information on active calls can be found here.